Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Atorvastatin GPO 40 mg vs Lipitor 40 mg Under Fasting Conditions
TCTR20191030002Not yet recruiting
- Sponsor
- Government Pharmaceutical Organization
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of atorvastatin in hypercholesterolemia, hyperlipidemia and dyslipidemia (2 arms), sponsored by Government Pharmaceutical Organization. Planned start Dec 2019; status: not yet recruiting.
02
Drugs
atorvastatin
03
Conditions
hypercholesterolemiahyperlipidemiadyslipidemia
Beyond the preview
Go deeper on TCTR20191030002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20191030002.